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Aim Diabetes is a major driver of cardiovascular disease, but the underlying mechanisms remain elusive. Prolyl-isomerase Pin1
recognizes specific peptide bonds and modulates function of proteins altering cellular homoeostasis. The present study
investigates Pin1 role in diabetes-induced vascular disease.
Methods
and results
In human aortic endothelial cells (HAECs) exposed to high glucose, up-regulation of Pin1-induced mitochondrial trans-
location of pro-oxidant adaptor p66Shc and subsequent organelle disruption. In this setting, Pin1 recognizes Ser-116
inhibitory phosphorylation of endothelial nitric oxide synthase (eNOS) leading to eNOS–caveolin-1 interaction
and reduced NO availability. Pin1 also mediates hyperglycaemia-induced nuclear translocation of NF-kB p65, trigger-
ing VCAM-1, ICAM-1, and MCP-1 expression. Indeed, gene silencing of Pin1 in HAECs suppressed p66Shc-
dependent ROS production, restored NO release and blunted NF-kB p65 nuclear translocation. Consistently,
diabetic Pin12/2 mice were protected against mitochondrial oxidative stress, endothelial dysfunction, and vascular in-
flammation. Increased expression and activity of Pin1 were also found in peripheral blood monocytes isolated from
diabetic patients when compared with age-matched healthy controls. Interestingly, enough, Pin1 up-regulation was
associated with impaired flow-mediated dilation, increased urinary 8-iso-prostaglandin F2a and plasma levels of adhe-
sion molecules.
Conclusions Pin1 drives diabetic vascular disease by causing mitochondrial oxidative stress, eNOS dysregulation as well as NF-kB-
induced inflammation. These findings provide molecular insights for novel mechanism-based therapeutic strategies in
patients with diabetes.
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Translational Perspective
The present studydemonstrates thatPin1 is a common activatorof key pathways involved in diabetic vascular disease in different experimental
settings including primary human endothelial cells, knockout mice, and diabetic patients. Gene silencing and genetic disruption of Pin1 prevent
hyperglycaemia-induced mitochondrial oxidative stress, endothelial dysfunction, and vascular inflammation. Moreover, we have translated
our findings to diabetic patients. In line with our experimental observations, Pin1 up-regulation is associated with impaired flow-mediated
dilation, increased oxidative stress, and plasma levels of adhesion molecules. In perspective, these findings may provide the rationale for
mechanism-based therapeutic strategies in patients with diabetes.
Introduction
Riskof cardiovascularcomplications is extremely high in patientswith
diabetes mellitus.1 In this setting, hyperglycaemia is a key player in the
development of atherosclerotic disease. Accumulation of reactive
oxygen species and inflammation are major features of diabetic vas-
cular phenotype.2 However, the underlying mechanisms remain to
be elucidated. A better understanding of the pathways involved in
hyperglycaemia-induced vascular damage may provide the basis for
novel therapeutic strategies to reduce the burden of cardiovascular
disease in patients with diabetes.
Phosphorylation of proteins on serine or threonine residues pre-
ceding proline is emerging as a key signalling mechanism in several
physiological and pathological processes.3 The peptidyl-prolyl cis-trans
isomerase Pin1 recognizes specific phosphorylated Ser/Thr-Pro-
peptidebonds and regulates their conformational changeswithhighef-
ficiency.3 Pin1-catalysed isomerization modulates function of proteins
involved incellularhomoeostasis.Ontheotherhand, impairedexpres-
sion and activity of Pin1 is implicated in the pathogenesis of cancer and
Alzheimer’s disease.4 Indeed, Pin1 is overexpressed in most human
cancers and correlateswith prognosis.5–7 This isomerase activates nu-
merous oncogenes/growth enhancers and inhibits crucial tumour sup-
pressors.4 Moreover, Pin1 is required for the activation of NF-kB
signalling in cancer cells8–10 and participates to mitochondrial localiza-
tion of oxidant proteins p66Shc and p53.11–14
Recent work has suggested that Pin1 may also play a role in the
vascular endothelium.15 In bovine endothelial cells, Pin1 negatively
modulates endothelial nitric oxide synthase (eNOS) activity via iso-
merization of the phosphorylated Ser-116 residue.15 In hypergly-
caemic conditions, p66Shc, eNOS, and NF-kB are key players
triggering vascular complications.2,16– 18 The mitochondrial adaptor
p66Shc is involved in the generation of reactive oxygen species
leading to cellular apoptosis and vascular damage. Although the
role of p66Shc as a regulator of lifespan in mammals has been chal-
lenged by recent controversial findings,19 its importance is well-
established in the setting of diabetic vascular complications.
Genetic deletion of p66Shc protects against ROS-dependent endo-
thelial dysfunction in diabetic mice.16 Notably, p66Shc expression is
increased in peripheral monocytes of patients with type 2 diabetes
(T2DM) and correlates with oxidative stress.20 Nitric oxide bioavail-
ability is a key marker of vascular health and preservation of eNOS
function warrants endothelial homoeostasis and prevents athero-
thrombosis.2,21,22 In addition, nuclear translocation of NF-kB p65
leads to endothelial up-regulation of adhesion molecules critically
involved in the diabetic atherosclerotic phenotype.23–25 Hence, Pin1-
dependent isomerization may alter function of proteins involved in the
diabetic vascular phenotype.18,26
In experimental and human diabetes, we show that Pin1 is
up-regulated by hyperglycaemia and triggers detrimental pathways
leading to vascular complications. Targeting Pin1 protects against
hyperglycaemia-induced mitochondrial oxidative stress, endothelial
dysfunction, and vascular inflammation and may provide novel
therapeutic insights in patients with diabetes.
Methods
A detailed description of the methods is provided in Supplementary
material online.
Cell culture
Human aortic endothelial cells (HAECs, passages 5–7) were exposed for
3 days either to normal glucose (5 mmol/L) or high glucose concentra-
tions (25 mmol/L). Mannitol (25 mmol/L) was used as an osmotic
control.
Animals
Four- to six-month-old male C57BL/6 mice, Pin1 WT mice and Pin12/2
mice were used in all the experiments. Animal experiments were con-
ducted in accordance with the guidelines approved by the Institutional
Animal CareCommitteeof theUniversityof Zu¨rich, Switzerland, Univer-
sity of Rome ‘Sapienza’ and University of Trieste, Italy.
Study population
Thirty-seven patients with T2DM and 20 age-matched healthy subjects
were consecutively recruited at the Cardiology Units of Sant’Andrea
Hospital, University ‘Sapienza’ and Catholic University (Rome, Italy).
The study protocol was approved by Local Ethics Committee and, in ac-
cordance with institutional Guidelines, all the participants were aware of
the investigational nature of the study and gave written consent for their
participation.
Statistical analysis
All data are presented as means+ SEM. Statistical comparison were
made by using Student’s t-test for unpaired data and one-way ANOVA,
followed by Bonferroni’s post hoc test, when appropriate. The between-
variable correlations were measured by Spearman’s analysis. Probability
values ,0.05 were considered statistically significant. All analyses were
performed with GraphPad Prism (version 5.0) and SPSS (version 20)
softwares.
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Results
High glucose increases Pin1 expression
and activity in human endothelial cells
To investigate the effects of hyperglycaemia on Pin1 expression,
HAECs were exposed to high (HG, 25 mmol/L) and normal (NG,
5 mmol/L) glucose concentrations for 72 h. High glucose levels
caused a significant up-regulation of Pin1 both at the mRNA and
protein level (Figure 1A). Moreover, HG increased enzyme activity
(Figure 1B). Interestingly, we found that Pin1 up-regulation is modu-
lated by DNA-related epigenetic changes. Indeed, Pin1 promoter
methylation, an important repressor of gene transcription, was
significantly reduced in HAECs exposed to high glucose when com-
pared with normal glucose (Figure 1C). Mannitol, used as an osmotic
control, did not exert any effect on Pin1 expression or activity (data
not shown).
Pin1 mediates p66Shc-dependent
mitochondrial ROS production
The molecular link between the isomerase Pin1 and mitochondrial
adaptor p66Shc was investigated by pull-down experiments per-
formed in HAECs exposed to HG and NG conditions. We observed
that Pin1 recognizes Ser-36 phosphorylation of p66Shc induced by
high glucose (Figure 1D and E). Interestingly, Pin1-dependent isomer-
ization is able to induce p66Shc mitochondrial translocation and sub-
sequent O2
2 generation (Figure 1F and G). Indeed, gene silencing of
Pin1 blunted mitochondrial translocation of p66Shc, preventing
hyperglycaemia-induced ROS generation (Figure 1F and G).
Knockdown of Pin1 prevents
mitochondrial network derangement
and cytochrome c release
Loss of mitochondrial integrity is emerging as a determinant of
endothelial dysfunction in diabetes.27 In this regard, we investigated
whether targeting Pin1 protects against hyperglycaemia-induced
mitochondrial network disruption. Under control conditions,
HAECs showed a complex network of thread-like mitochondria
while exposure to high glucose induced a marked loss of mitochon-
drial networks characterized by smaller punctuate mitochondria, as
shown by a confocal microscopy (Figure 2A). Interestingly, Pin1
knockdown prevented mitochondrial rupture and DNA fragmenta-
tion (Figure 2A and B). Moreover, isolated mitochondria were chal-
lenged with calcium overload and the rate of swelling determined
by light scattering. Organelles from HAECs exposed to normal
glucose showed stable absorbance throughout the 20-min time-
course. In contrast, HG-treated cells displayed mitochondrial
Figure 1 Hyperglycaemia-induced Pin1 up-regulation mediates mitochondrial oxidative stress in human aortic endothelial cells. (A and B) Pin1
gene (n ¼ 5) and protein (n ¼ 6) expression, as well as Pin1 activity (n ¼ 7) in human aortic endothelial cells exposed to normal and high
glucose concentrations. (C) Quantitative analysis of Pin1 promoter methylation in human aortic endothelial cells (n ¼ 6). UM, unmethylated; IM,
intermediately methylated; HM, hypermethylated CpG dinucleotides. (D) Western blot and densitometric quantification of p66Shc activating
Ser-36 phosphorylation in human aortic endothelial cells exposed to normal and high glucose concentrations (n ¼ 4). (E) Western blot showing
the interaction of Pin1 with the mitochondrial adaptor p66Shc upon high glucose exposure. IB, immunoblotting; IP, immunoprecipitation. (F)
Western blot showing p66Shc mitochondrial translocation in cells exposed to normal and high glucose in the presence or in the absence of Pin1
siRNA. Scrambled siRNAwasused as a control. GAPDH and COX4 indicate loading controls for cytosolic and mitochondrial fractions, respectively.
(G) ESR spectroscopy analysis of mitochondrial O2
2 generation (n ¼ 7). Results are presented as means+ SEM. NG, normal glucose; HG, high
glucose, O2
2, superoxide anion.
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swelling which was prevented by Pin1 down-regulation (Figure 2C).
Silencing of Pin1 also protected against glucose-induced cytochrome
c release, as assessed by double staining and western blot (Figure 2D
and E).
Pin1 inhibits endothelial nitric oxide
synthase activity
On the basis of previous studies showing that Pin1 regulates eNOS
activity, we investigated whether Pin1 may affect eNOS in the pres-
ence of HG concentration. We found that endothelial NO release
was impaired after exposure to HG, whereas concomitant silencing
of Pin1 restored NO availability (Figure 2F). Pull-down experiments
demonstrated that Pin1 recognizes high glucose-induced Ser-116
eNOS inhibitory phosphorylation, favouring association of eNOS
with caveolin-1, an important repressor of eNOS catalytic activity28
(Figure 2G– I ). Accordingly, Pin1 knockdown prevented eNOS–
caveolin-1 interaction, contributing to the preservation of NO
availability in our setting (Figure 2I).
Pin1 mediates hyperglycaemia-induced
up-regulation of adhesion molecules
Since Pin1 is a critical mediator of inflammation in cancer, we inves-
tigated whether this isomerase contributes to endothelial inflamma-
tion in hyperglycaemic conditions. Exposure to HG caused a
Figure 2 Targeting Pin1 rescues hyperglycaemia-induced mitochondrial disruption and endothelial nitric oxide synthase dysregulation. (A) Con-
focal microscopy images of mitoTracker-based mitochondrial staining showing alteration of an organelle network in human aortic endothelial cells
exposed to high glucose in the presence or in the absence of Pin1 siRNA. Under normal glucose concentrations, human aortic endothelial cells show
thread-likemitochondria (Figure1A andB)while exposure tohigh glucose leads to smallerpunctuatemitochondria (Figure2A andB). Pin1knockdown
significantly attenuated mitochondrial disruption (Figure 3A and B). Scrambled siRNAwas used as a control (Figure 4A and B). (B) Mitochondrial DNA
integrity by real-time PCR (n ¼ 6). *P, 0.01 vs. NG§; P, 0.01 vs. HG. (C) Mitochondrial swelling assay. Line graphs represent time-course of light
absorbance decrease with (blue line) and without (red line) calcium overload (n ¼ 6). *P, 0.05 vs. untreated. (D) Confocal microscopy images
showing cytochrome c (green) release (arrows) from mitochondria stained with organelle marker MitoTracker (red). (E) Representative
western blot (WB) showing cytochrome c release from mitochondria. (F ) ESR spectroscopy analysis of nitric oxide release across the experimental
conditions (n ¼ 6). (G) Western blot and densitometric quantification of endothelial nitric oxide synthase inhibitory Ser-116 phosphorylation in
human aortic endothelial cells exposed to normal and high glucose concentrations (n ¼ 4). (H ) Immunoprecipitation showing endothelial nitric
oxide synthase–Pin1 association in cells exposed to normal or high glucose concentrations. (I ) Endothelial nitric oxide synthase–caveolin-1 inter-
action in high glucose-treated human aortic endothelial cells with or without Pin1 siRNA. IB, immunoblotting; IP, immunoprecipitation. Results are
presented as means+ SEM. NG, normal glucose, HG, high glucose.
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significant up-regulation of the adhesion molecules vascular adhesion
cell molecule-1 (VCAM-1), intercellular cell adhesion molecule -1
(ICAM-1), and MCP-1 in HAECs (Figure 3A). In this setting, Pin1
recognizes NF-kB p65 favouring its nuclear translocation and
increased binding activity (Figure 3B–D). Interestingly, Pin1 down-
regulationbysiRNAprevented NF-kBp65activationand subsequent
overexpression of adhesion molecules (Figure 3A, C and D).
Diabetic Pin12/2 mice are protected
against endothelial dysfunction
Diabetes induced a significant increase of Pin1 expression in mouse
aorta (Figure 4A). WT and Pin12/2 mice were studied to investigate
whether Pin1 contributes to hyperglycaemia-induced endothelial
dysfunction in vivo. Diabetic animals did not differ for body weight,
glucose levels, blood pressure, and lipids (Supplementary material
online, Table S1). Endothelial function was normal in control WT
and Pin12/2 mice (Figure 4B). Interestingly, enough, endothelium-
dependent relaxation to acetylcholine (1029–1026 mol/L) was
impaired in WT diabetic mice but not in Pin12/2 mice (Figure 4B).
In contrast, endothelium-independent relaxation to sodium nitro-
prusside (10210–1025 mol/L) did not differ across the experimental
groups (data not shown).
Genetic deletion of Pin1 prevents
mitochondrial oxidative stress
In line with our in vitro findings, mitochondrial ROS generation
was abolished in Pin12/2 diabetic vessels (Figure 4C). Accordingly,
genetic disruption of the isomerase prevented diabetes-related
mitochondrial DNA fragmentation and swelling, two important hall-
marks of mitochondrial dysfunction (Figure 4D and E). To further in-
vestigate the link between Pin1 and vascular dysfunction in vivo,
knockdown of Pin1 was achieved by using siRNA technology in
WT diabetic mice. Interestingly, Pin1 silencing rescued endothelial
dysfunction when compared with scrambled-treated WT diabetic
mice (Figure 4F).
Figure 3 Pin1 triggers up-regulation of inflammatory adhesion molecules via nuclear factor kappa-B signalling. (A) Gene expression of inflamma-
tory adhesion molecules vascular adhesion cell molecule-1, intercellular cell adhesion molecule-1, and MCP-1 in human aortic endothelial cells
exposed to normal and high glucose concentrations in the presence or in the absence of Pin1 siRNA (n ¼ 6). *P, 0.01 vs. NG§; P, 0.01 vs.
HG. (B) Immunoprecipitation showing the interaction between Pin1 and NF-kB p65 in cells treated with high or normal glucose. IB, immunoblotting;
IP, immunoprecipitation. (C) Representative western blot showing NF-kB p65 nuclear translocation. GAPDH and Histone 1 indicate loading con-
trols for cytosolic and nuclear fractions, respectively. (D) NF-kB p65 binding activity (n ¼ 5). Results are presented as means+ SEM. NG, normal
glucose, HG, high glucose. VCAM-1, vascular adhesion cell molecule-1; ICAM-1, intercellular cell adhesion molecule-1; MCP-1, monocyte chemo-
attractant protein-1, NF-kB, nuclear factor kappa-B.
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Suppression of diabetes-induced vascular
inflammation in Pin12/2 mice
To investigate the effects of Pin1 on vascular inflammation, the ex-
pression of VCAM-1 and ICAM-1 was assessed in the aorta of WT
and Pin12/2 diabetic mice. Aortas isolated from WT diabetic mice
displayed a significant up-regulation of these adhesion molecules,
as shown by immunofluorescence and real-time PCR (Figure 5A
and B). Such an effect was explained by increased NF-kB p65
nuclear translocation and binding activity (Figure 5C and D). Interest-
ingly, we found that diabetic mice lacking Pin1 were protected against
vascular inflammation (Figure 5A–D).
Pin1 expression and activity in patients
with diabetes
Pin1 gene expression and activity were assessed in peripheral blood
monocytes of 37 patients with T2DM and 20 age-matched healthy
controls. Type 2 diabetes mellitus subjects had higher BMI, waist cir-
cumference, blood pressure, and lower HDL levels (Supplementary
material online, Table S2). Expression and activity of Pin1 were
increased in T2DM and correlated with HbA1c as well as fasting
plasma glucose (FPG, Figure 6A–C ).
Importantly, FPG (b ¼ 0.39, P ¼ 0.021) and HbA1c (b ¼ 0.31,
P ¼ 0.034) were independently associated with Pin1 gene expres-
sion, as shown by linear regression analysis adjusted for age,
gender, waist circumference, blood pressure, HDL, and medications.
Pin1 up-regulation, endothelial
dysfunction, and oxidative stress
Endothelial function, assessed by flow-mediated dilation (FMD), was
significantly impaired in T2DM subjects when compared with
controls (Supplementary material online, Table S3). Nitroglycerine-
mediated dilatation was comparable in the two groups (Supplemen-
tary material online, Table S3) and no differences were observed in
arterial diameter as well as resting or hyperaemic flow (data not
shown). In agreement with an impairment of endothelial function,
diabetic patients showed higher urinary levels of 8-isoPGF2a, in vivo
Figure4 GeneticdeletionofPin1 protects againstdiabetes-relatedendothelial dysfunctionand mitochondrial oxidative stress. (A)Representative
western blot and densitometric quantification of Pin1 expression in the aorta of WT and Pin12/2 mice, with or without diabetes (n ¼ 5). ND, not
detectable. (B) Isometric tension studies in aortic rings isolated from the four experimental groups (WT control ¼ 10, WT diabetic ¼ 12, Pin12/2
control ¼ 8, Pin12/2 diabetic ¼ 7) per group. *P, 0.05 and **P, 0.01 vs. WT diabetic. NE, norepinephrine. (C) ESR spectroscopy analysis of
mitochondrial superoxide anion (O2
2) generation (n ¼ 6). (D) Mitochondrial DNA integrity assessed by real-time PCR in the four experimental
groups (n ¼ 7). *P, 0.01 vs. WT control§; P, 0.01 vs. WT diabetic. (E) Mitochondrial swelling assay (n ¼ 6). *P, 0.05 vs. untreated. (F)
Endothelium-dependent relaxation in diabetic mice treated with scramble or Pin1 siRNA. *P, 0.05 and **P, 0.01 vs. scrambled siRNA.
Results are presented as means+ SEM.
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marker of oxidative stress (Supplementary material online, Table S3).
Interestingly enough, Pin1 gene expression and activity significantly
correlated with endothelial dysfunction and oxidative stress
(Figure 7A and B). This finding was confirmed by linear regression ana-
lysis adjusted for confounding factors (Supplementary material
online, Table S4).
Pin1 correlates with plasma adhesion
molecules
We also investigated the correlation between Pin1 and plasma adhe-
sion molecules. Vascular adhesion cell molecule-1, ICAM-1, and
MCP-1 were significantly higher in T2DM when compared with con-
trols (Supplementary material online, Table S4). Of interest, a signifi-
cant association was found between Pin1 expression/activity and
adhesion molecules, as shown by correlation and linear regression
analysis (Figure 8A, Supplementary material online, Table S4). Collect-
ively, these findings show that Pin1 may be critically involved in the
vascular disease phenotype observed in diabetic patients (Figure 8B).
Discussion
Here, we show that Pin1 is up-regulated by hyperglycaemia and
orchestrates pivotal molecular events triggering diabetic vascular
disease. Several lines of evidence support our conclusions. Pin1 ex-
pression and activity are significantly increased in human endothelial
cells exposed to high glucose and in aortas of diabetic mice.
Activatory Ser-36 phosphorylation of adaptor protein p66Shc is spe-
cifically recognized by Pin1 and this leads to p66Shc mitochondrial
translocation, ROS production, and organelle disruption. Pin1 also
recognizes Ser-116 eNOS inhibitory phosphorylation contributing
to impaired NO availability. Furthermore, this isomerase is required
for hyperglycaemia-induced nuclear translocation of NF-kB p65,
leading to up-regulation of inflammatory adhesion molecules. Im-
portantly, genetic deletion of Pin1 prevented vascular oxidative
stress, endothelial dysfunction, and NF-kB-driven inflammation in
diabetic mice. In addition, the expression and activity of Pin1 are
increased in peripheral blood monocytes of T2DM patients and
correlate with brachial artery FMD, urinary levels of the oxidative
marker 8-isoPGF2a, and plasma adhesion molecules.
Pin1 is emerging as a novel regulator of cellular function via
modifications of protein structure upon recognition of a specific
phosphorylation motif (Ser/Thr-Pro).29 Pin1-dependent isomeriza-
tion leads to stabilization of proteins in active configuration and
enhances their degradation or accessibility for further modifica-
tions by other enzymes.3 The biological relevance of such a signal-
ling mechanism is supported by the notion that Pin1 dysregulation
may contribute to diverse pathological conditions such as cancer
and Alzheimer’s disease.3,4 Indeed, this isomerase is overexpressed
in 38 out of 60 different human cancers and predicts prognosis.5– 7
In cancer cells, Pin1 recognizes a phosphorylated Thr-254-Pro
motif of NF-kB p65 and inhibits its binding to IkBa, resulting in
increased nuclear translocation.8 Moreover, Pin1 controls mito-
chondrial trafficking of pro-oxidant proteins.11,13,30 In murine
Figure5 Loss of Pin1 suppresses vascular inflammation in diabetic mice. (A) Fluorescence microscopy images showing the expression of adhesion
molecules vascular adhesion cell molecule-1 and intercellular cell adhesion molecule-1 (green) in aortic cross sections from WT and Pin12/2 mice
with or without diabetes. Nuclei stained blue with DAPI. Higher magnification panels (bottom) show vascular adhesion cell molecule-1 and inter-
cellular cell adhesion molecule-1 signals only in WT diabetic mice (arrows). (B) Gene expression of vascular adhesion cell molecule-1 and intercel-
lular cell adhesion molecule-1 by real-time PCR (n ¼ 8). *P, 0.01 vs. WT control§; P, 0.01 vs. WT diabetic. (C) Representative western blot of
NF-kB p65 nuclear translocation in aortas isolated from the different experimental groups. (D) NF-kB p65 binding activity (n ¼ 5). Results are pre-
sented as means+ SEM.
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fibroblasts, Pin1 blockade prevents translocation of p66Shc to the
mitochondria and oxidative stress.11 Although Pin1 is an emerging
trigger of proliferative, inflammatory, and pro-apoptotic signalling
in cancer, its role in the pathogenesis of vascular disease remains
to be elucidated. A recent work in bovine endothelial cells
showed that Pin1 recognizes Ser-116 eNOS inhibitory phosphor-
ylation and blunts NO release.15 Indeed, pharmacological blockade
of Pin1 induced a 30% increase in NO production.15 Since mito-
chondrial oxidative stress, reduced NO availability, and vascular in-
flammation are major hallmarks of diabetic vascular disease,18 we
were prompted to investigate whether Pin1 is affected by hyper-
glycaemia and mediates vascular damage in this setting. Our find-
ings show that Pin1 is up-regulated by high glucose levels and is
responsible for mitochondrial translocation of p66Shc in the vascu-
lar endothelium. We and others have demonstrated that p66Shc is
a key mediator of ROS generation and, hence, a major contributor
of diabetic vascular complications.16,17,31,32 Of note, p66Shc gene
expression is increased in mononuclear cells obtained from
patients with T2DM and correlates with oxidative stress.20 The
present study demonstrates that Pin1 is the upstream regulator
Figure 6 Pin1 expression and activity are increased in diabetic patients and correlate with glycaemic markers. (A) Scatter plots show Pin1 mRNA
(controls ¼ 20, T2DM ¼ 37) and activity (controls ¼ 12, T2DM ¼ 37) in diabetic subjects and healthy controls. Results are presented as means+
SEM. (B andC) Correlation of Pin1 expression and activity with HbA1c and FPG. r ¼ Spearman’s correlation coefficient. HbA1c indicates glycosylated
haemoglobin; FPG, fasting plasma glucose.
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of p66Shc and its inhibition prevents oxidative stress and mitochon-
drial disruption in human endothelial cells and in mice under
hyperglycaemic conditions. The relevance of our results is
strengthened by recent work suggesting that loss of mitochondrial
integrity may affect endothelial function in diabetic patients.27,33
We also found that in hyperglycaemic conditions Pin1 impairs
eNOS activity via isomerization of its inhibitory Ser-116 residue.
Proline-directed phosphorylation, requiring a proline at the P + 1
position, is a pre-requisite for Pin1 interaction and subsequent iso-
merization of its substrates. Of the five known serine/threonine
phosphorylation sites in human eNOS, only Ser-116 conforms to
the P + 1 proline requirement.34 In our study, Pin1 isomerizes
Ser-116 favouring eNOS interaction with caveolin-1, an important
repressorof eNOS catalytic activity in the endothelium.28,35 Accord-
ingly, Pin1 deletion suppressed eNOS trafficking to the plasmalem-
mal caveolae and restored NO availability. This finding is supported
by another study showing that transient Pin1 overexpression blunts
NO release in unstimulated endothelial cells.15 Furthermore, silen-
cing of Pin1 prevents hyperglycaemia-induced oxidative stress in
renal tubular cells12 and neointima formation in mice byaffecting pro-
liferation of vascular smooth muscle cells.12,36,37 These latter studies
provided insights on the role of Pin1 in the vessel wall. However, our
work demonstrates for the first time that Pin1 activation is a key
driver of vascular damage in diabetes. Indeed, this study clearly
shows that hyperglycaemia-induced Pin1 up-regulation leads to a
deleterious vascular phenotype which can be prevented by targeting
Pin1. Accordingly, Pin12/2 diabetic mice are protected against
hyperglycaemia-induced endothelial dysfunction and mitochondrial
oxidative stress.
We also provide strong evidence that Pin1 drives vascular inflam-
mation in the setting of diabetes. Although it was recently shown that
Pin1 promotes NF-kB p65 signalling in cancer cells,8 no previous
work investigated whether this isomerase mediates inflammation in
the cardiovascular system. In our study Pin1-induced NF-kB p65
nuclear translocation and up-regulation of adhesion molecules
in vitro and in vivo. We show here that deletion of Pin1 suppresses
NF-kB p65 and expression of VCAM-1, ICAM-1, and MCP-1.
These findings deserve attention since NF-kB activation has been
reported in the endothelium of humans with T2DM.23
In contrast with our results, a previous study showed that
Pin12/2 mice exhibit a significant impairment of endothelium-
dependent relaxation and high blood pressure values.38 Here, we
Figure 7 Pin1 correlates with endothelial function and oxidative stress. (A and B) Correlation of Pin1 expression and activity with flow-mediated
vasodilation and urinary 8-isoPGF2a levels. Red and blue circles indicate healthy controls (n ¼ 12–20) and T2DM patients (n ¼ 37), respectively.
FMD, flow-mediated dilation; 8-isoPGF2a, 8-iso-prostaglandin F2a. r ¼ Spearman’s correlation coefficient.
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do not observe any endothelial dysfunction or hypertension in mice
lacking Pin1. Different age of animals and experimental conditions
may contribute to explain such discrepancy. In line with our find-
ings, it was recently reported that blood pressure values and
cardiac phenotype are comparable in WT and Pin12/2 mice.39 Add-
itional experimental observations suggest that silencing of Pin1 pre-
vents angiotensin II-dependent oxidative stress, indicating that Pin1
blockade may rather be protective against arterial hypertension.12
Another study also confirmed our results by showing that
Pin1 overexpression impairs endothelium-dependent vasorelaxa-
tion in mice.15
In the present study, we have also translated our experimental
findings to diabetic patients. Indeed, we found a significant
up-regulation of Pin1 in subjects with T2DM when compared with
age-matched healthy controls. Moreover, Pin1 correlated with bra-
chial artery FMD, urinary 8-isoPGF2a, and plasma levels of adhesion
molecules. Linear regression analyses showed that Pin1 was asso-
ciated with oxidative stress, endothelial dysfunction, and vascular in-
flammation regardless of confounding factors. FPG and HbA1c were
also independent predictors of Pin1 up-regulation. Although the
assessment of Pin1 expression in peripheral monocytes cannot be
directly related to endothelial dysfunction, these findings are in
Figure 8 Pin1 correlates with inflammatory adhesion molecules in patients with diabetes. (A) Correlation of Pin1 expression and activity with
plasma adhesion molecules vascular adhesion cell molecule-1, intercellular cell adhesion molecule-1, and monocyte chemoattractant protein-1.
Red and blue circles indicate healthy controls (n ¼ 12–20) and diabetic patients (n ¼ 37), respectively. r ¼ Spearman’s correlation coefficient.
VCAM-1, vascular adhesion cell molecule-1; ICAM-1, intercellular cell adhesion molecule-1; MCP-1, monocyte chemoattractant protein-1.
(B) Schematic representation of the Pin1 role in diabetic vascular disease. Diabetes causes up-regulation of Pin1 favouring its interaction with phos-
phorylated serine and threonine residues of adaptor protein p66Shc, endothelial nitric oxide synthase, and NF-kB p65. Pin1-p66Shc interaction is
required for translocation of p66Shc, mitochondrial ROS generation, and disruption. Phosphorylated endothelial nitric oxide synthase at Ser-116
is recognized by Pin1 leading to endothelial nitric oxide synthase–caveolin-1 interaction, blunted endothelial nitric oxide synthase activity and
reduced NO release. Pin1 also triggers diabetes-induced nuclear translocation of NF-kB p65 and subsequent up-regulation of inflammatory adhe-
sion molecules. All together these findings indicate that Pin1-induced conformational changes are critically involved in the diabetic vascular disease
phenotype.
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accordance with our experiments in HAECs demonstrating a key
role of the isomerase in the human endothelium. The strength
of our work is the observation of Pin1 as a key mediator of
hyperglycaemia-relatedvascular damage across different experimen-
tal settings including knockout mice, primary human endothelial cells,
and T2DM patients. Another novel finding is that hyperglycaemia
reduces methylation of the Pin1 promoter. Since methylation is an
important repressor of gene transcription,40,41 our findings suggest
that this epigenetic signature may contribute to Pin1 up-regulation
in this setting. Undoubtedly, further studies are needed to better
characterize epigenetic-driven Pin1 transcription in disease states.
In conclusion, we have shown that Pin1-dependent isomerization
modulates key proteins involved in diabetic vascular disease
(Figure 8B). Targeting Pin1 may restore vascular health by preventing
such deleterious events. These findings have important implications
for future mechanism-based therapeutic strategies in patients with
diabetes.
Supplementary material
Supplementary material is available at European Heart Journal online.
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Extensive xanthomas with severe coronary artery disease in a young patient
with familial hypercholesterolemia
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A 20-year-old female presented to us with recent
onset unstable angina. She had a strong family his-
tory of premature coronary artery disease (two
elder sisters dying at a young age due to CAD). She
had large tendinous xanthomas over extensor
tendons of metacarpophalangeal joints and patella
(Panels A–C). She also had xanthelesma, gaint tuber-
ous xanthomas over extensor aspects of limbs and
buttocks and Plane xanthoma involving the neck
(Panels D–H). The ECG showed deep ST depres-
sion in all leads with ST elevation in avR (left main
pattern, Panel I). Laboratory tests showed total
cholesterol of 810 mg/dL (20.9 mmol/L), low-
density lipoprotein cholesterol (LDL) of 733 mg/
dL (18.9 mol/L), triglycerides (TG) of 195 mg/dL
(2.2 mmol/L), and high-density lipoprotein choles-
terol of 39 mg/dL (1.0 mmol/L). Her coronary angi-
ography revealed severe left main disease involving ostium and mid shaft and also ostial RCA disease (Panels I, J, and K). Genetic study
showed homozygotic mutation in LDL receptor gene. The patient is being planned for urgent PCI with intensive medical therapy.
Panel A: Large tendinous xanthomas over extensor tendons of metacarpophalangeal joints.
Panel B: Large tendinous xanthomas over extensor tendons of metatarsophalangeal joints.
Panel C: Large tendinous xanthomas over patella.
Panel D: Xanthelesma.
Panel E: Gaint tuberous xanthomas over extensor aspects of elbow.
Panel F: Gaint tuberous xanthomas buttocks.
Panel G: Plane xanthoma involving the neck.
Panel H: Xanthoma involving extensor aspect of forearm.
Panel I: ECG showing deep ST depression in all leads with ST elevation in avR (left main pattern).
Panel J: Coronary angiography showing severe left main disease involving ostium and mid shaft.
Panel K: Coronary angiography showing severe ostial RCA disease.
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